Covid-19 roundup: In­side CTAP: 270 tri­als un­der­way, 570+ in the FDA line; WHO chief calls out 'vac­cine na­tion­al­is­m'

More than 270 clin­i­cal tri­als for po­ten­tial Covid-19 drugs have been cleared by the FDA, ac­cord­ing to the agency, with an­oth­er 570 pro­grams be­ing hus­tled in a mad rush to de­vel­op ther­a­pies that can ad­dress the myr­i­ad ways the coro­n­avirus in­fec­tion af­flicts pa­tients.

Even as the NIH spear­head­ed ef­forts to gen­er­ate sol­id da­ta for the most promis­ing can­di­dates through large-scale mas­ter pro­to­cols, the FDA kept its door open for in­di­vid­ual drug de­vel­op­ers and their ex­per­i­men­tal and re­pur­posed drugs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER